Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Acute Myeloid Leukemia
74%
Mycophenolate Mofetil
56%
Graft-versus-host Disease (GvHD)
52%
T Cells
40%
Myelodysplastic Syndrome
40%
Suicide Gene
39%
Japan
35%
Hematopoietic Cell Transplantation
33%
Post-transplantation Cyclophosphamide (PTCy)
33%
Bone Marrow
31%
Remission
30%
Vitamin D Receptor
28%
Hematopoietic Stem Cells
24%
Optimal Dose
24%
Osteocyte
24%
B-cell Lymphoma
23%
Macrophages
23%
Pharmacokinetics
22%
Therapy-related Myelodysplastic Syndrome (t-MDS)
22%
Allogeneic Transplant
22%
Paroxysmal Nocturnal Hemoglobinuria
22%
Eculizumab
22%
Chimeric Antigen Receptor T Cells (CAR-T)
22%
Reduced Intensity
20%
Hazard Ratio
19%
Cytogenetic Aberrations
19%
Hematopoietic Stem Cell Transplantation
19%
Pretransplant
18%
CD33
18%
Mycophenolic Acid
17%
Confidence Interval
16%
Cell Therapy
16%
Granulocyte Colony-stimulating Factor (G-CSF)
16%
Complex Karyotype
15%
T Cell Activation
14%
Methotrexate
14%
Improved Outcomes
14%
Lymphoma
14%
Caspase-9
14%
Multiple Myeloma Patients
14%
Transplantation
13%
T-cell chimerism
13%
Cell Removal
13%
Conditioning Regimen
13%
Reduced-intensity Conditioning
13%
Myeloablative Conditioning
13%
Follicular Lymphoma
13%
Relapsed or Refractory
13%
Bone Marrow Involvement
13%
Immunology and Microbiology
Myeloid
69%
T Cell
69%
Graft-Versus-Host Disease
66%
Hematopoietic Cell
57%
Mycophenolate Mofetil
56%
Cell Transplantation
44%
Conditioning
41%
Allogeneic Hematopoietic Stem Cell Transplantation
41%
Cyclophosphamide
35%
B Cell
34%
Stem Cell Transplant
26%
Chimeric Antigen Receptor
25%
Optimal Drug Dose
24%
Pharmacokinetics
24%
Osteocyte
24%
Chimera
23%
Granulocyte Colony-Stimulating Factor
23%
Mycophenolic Acid
22%
Hematopoietic Stem Cell Transplantation
22%
Macrophage
20%
Chimeric Antigen Receptor T-Cell
19%
CD33
19%
Neutrophil
18%
Lymphoma Cell
16%
Methotrexate
16%
Human Leukocyte Antigen
14%
Transgenics
14%
Lineages
14%
Acute Graft Versus Host Disease
12%
Cytokine Production
12%
Cytotoxic T-Cell
12%
Host
12%
Cytokine
12%
Lymphocyte
11%
Allogeneic Stem Cell Transplantation
11%
Fluorescence in Situ Hybridization
11%
Transgenic Mouse
11%
Lipid Metabolism
11%
Mediator Complex
11%
Multiple Myeloma
11%
Lymphoid Organ
11%
Gene Product
11%
Erythroblast
11%
Eculizumab
11%
CD163
11%
Virotherapy
11%
Autologous Stem Cell Transplantation
11%
Sympathetic Tone
11%
Hemophagocytic Lymphohistiocytosis
11%
Prostaglandin E2
11%
Medicine and Dentistry
Acute Myeloid Leukemia
86%
T Cell
41%
Transplantation
41%
Leukemia
39%
Follicular Lymphoma
39%
Myelodysplastic Syndrome
34%
Allogeneic Hematopoietic Stem Cell Transplantation
25%
B-Cell Lymphoma
23%
Cyclophosphamide
22%
Osteosclerosis
22%
Cell Transplantation
22%
Leukemia Relapse
22%
Graft Versus Host Reaction
21%
Hematopoietic Stem Cell Transplantation
20%
Chromosome Analysis
17%
Vitamin D Receptor
17%
In Vitro
16%
Chimeric Antigen Receptor
16%
Chimeric Antigen Receptor T-Cell
16%
Conditioning
16%
Macrophage
14%
Stem Cell Transplant
14%
Progenitor Cell
14%
Osteocyte
13%
Graft Failure
13%
Sensitivity and Specificity
12%
Zinc Finger Protein
12%
Overall Survival
11%
Subdural Hematoma
11%
Autotransplantation
11%
Splenomegaly
11%
Membrane Antigen
11%
Uterine Cancer
11%
Cell Nucleus Receptor
11%
Retinoblastoma Protein
11%
Allogenic Bone Marrow Transplantation
11%
Fibroblast Growth Factor 23
11%
Myelofibrosis
11%
Vitamin D
11%
Cytopenia
11%
Myeloablative Conditioning
11%
Lymphoid Organ
11%
Reduced Intensity Conditioning
11%
Pelvis
11%
Large-Cell Lymphoma
11%
Lymphocytosis
11%
Peroxisome Proliferator Activated Receptor
11%